FDA Drug Recalls

Recalls / Class III

Class IIID-0244-2021

Product

Phytonadione Tablets 5mg, 30-count bottle, Rx Only, Manufactured For: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA NDC 68682-170-30

Affected lot / code info
Lot: 18L091P, Exp 05/2021

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Recalling firm

Firm
Bausch Health Companies, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
400 Somerset Corporate Blvd, Bridgewater, New Jersey 08807-2867

Distribution

Quantity
14,089 bottles
Distribution pattern
Distributed Nationwide in the USA

Timeline

Recall initiated
2021-01-07
FDA classified
2021-01-25
Posted by FDA
2021-02-03
Terminated
2022-02-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0244-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls